| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.36▲ | 1.26▲ | 1.22▲ | 1.37▲ | 1.56▼ |
| MA10 | 1.25▲ | 1.19▲ | 1.20▲ | 1.48▼ | 1.54▼ |
| MA20 | 1.21▲ | 1.21▲ | 1.26▲ | 1.58▼ | 1.10▲ |
| MA50 | 1.25▲ | 1.38▼ | 1.44▼ | 1.50▼ | 1.03▲ |
| MA100 | 1.39▼ | 1.49▼ | 1.55▼ | 1.06▲ | 4.90▼ |
| MA200 | 1.48▼ | 1.58▼ | 1.69▼ | 0.91▲ | 7.32▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.033▲ | 0.035▲ | 0.021▲ | -0.056▼ | 0.077▲ |
| RSI | 65.735▲ | 61.433▲ | 54.052▲ | 44.202▼ | 52.853▲ |
| STOCH | 97.814▲ | 63.423 | 41.834 | 15.573▼ | 57.483 |
| WILL %R | -6.557▲ | -6.557▲ | -6.557▲ | -61.176 | -50.568 |
| CCI | 87.926 | 174.824▲ | 129.451▲ | -145.894▼ | 3.319 |
| ▲ GAP | $ALXO Open Gap Up %2 | Set Alert |
|
Friday, November 07, 2025 12:57 PM
Discover ALX Oncology’s Q3 2025 earnings call insights, featuring breakthrough ASPEN-06 data and biomarker-driven cancer strategies.
|
|
Friday, November 07, 2025 05:29 AM
ASPEN-06 data to be presented at SITC demonstrates that evorpacept drove durable clinical benefit across all efficacy measures in HER2+ gastric cancer patients with high CD47 expression Phase 2 ...
|
|
Friday, November 07, 2025 05:26 AM
We are pleased to share data at SITC this weekend from an analysis of our ASPEN-06 trial demonstrating compelling benefit in all outcomes ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/11/25 | 1.21 | 1.41 | 1.05 | 1.38 | 758,147 |
| 06/11/25 | 1.26 | 1.365 | 1.13 | 1.18 | 824,612 |
| 05/11/25 | 1.50 | 1.5273 | 1.25 | 1.26 | 546,714 |
| 04/11/25 | 1.52 | 1.5997 | 1.46 | 1.46 | 303,479 |
| 03/11/25 | 1.57 | 1.64 | 1.54 | 1.57 | 166,038 |
| 31/10/25 | 1.52 | 1.55 | 1.49 | 1.54 | 99,872 |
| 30/10/25 | 1.57 | 1.61 | 1.52 | 1.55 | 123,047 |
| 29/10/25 | 1.54 | 1.61 | 1.513 | 1.59 | 197,553 |
| 28/10/25 | 1.66 | 1.68 | 1.53 | 1.54 | 254,685 |
| 27/10/25 | 1.75 | 1.77 | 1.62 | 1.70 | 410,241 |
|
|
||||
|
|
||||
|
|